8-K
Current Report
Atara Biotherapeutics, Inc. Filed Acc 0001193125-21-186845
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d193498d8k.htm…